Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Acta cir. bras ; 26(5): 339-345, Sept.-Oct. 2011. graf, tab
Article in English | LILACS | ID: lil-599634

ABSTRACT

PURPOSE: People consume vegetables without the knowledge of the side effects of the biological and chemical contents and interactions between radiopharmaceuticals and herbal extract. To this end, current study is focused on the effects of broccoli extract on biodistribution of radiolabeled glucoheptonate (99mTc-GH) and radiolabeling of blood components. METHODS: GH was labeled with 99mTc. Quality control studies were done utilizing TLC method. Biodistribution studies were performed on male rats which were treated via gavage with either broccoli extract or SF as control group for 15 days. Blood samples were withdrawn from rats' heart. Radiolabeling of blood constituents performed incubating with GH, SnCl2 and 99m Tc. RESULTS: Radiochemical yield of 99mTc-GH is 98.46±1.48 percent (n=8). Biodistribution studies have shown that according to the control, the treated group with broccoli has approximately 10 times less uptake in kidney. The percentage of the radioactivity ratios of the blood components is found to be same in both groups. CONCLUSIONS: Although there is no considerable effect on the radiolabeling of blood components, there is an outstanding change on the biodistribution studies especially on kidneys. The knowledge of this change on kidney uptake may contribute to reduce the risk of misdiagnosis and/or repetition of the examinations in Nuclear Medicine.


OBJETIVO: As pessoas consomem verduras sem o conhecimento dos efeitos colaterais dos conteúdos biológicos e químicos e interações entre os medicamentos radiofarmacêuticos e os extratos vegetais. Para este fim, o estudo atual é focado sobre os efeitos do extrato de brócolis na biodistribuição do fármaco glucoheptonato (99mTc-GH) e da marcação de componentes do sangue. MÉTODOS: GH foi marcado com 99mTc. Estudos de controle de qualidade foram feitos utilizando o método do TLC. Os estudos de biodistribuição foram realizados em ratos machos que foram tratados por gavagem com um extrato de brócolis ou SF como grupo controle para 15 dias. Amostras de sangue foram retiradas do coração de ratos. Marcação de constituintes sanguíneos realizados incubação com SnCl2 GH e 99mTc. RESULTADOS: Radioquímica rendimento de 99mTc-GH é 98,46 ± 1,48 por cento (n = 8). Os estudos de biodistribuição mostraram que de acordo com o controle, o grupo tratado com brócolis tem aproximadamente 10 vezes menor absorção no rim. O percentual do ratio de radioatividade dos componentes do sangue é encontrado para ser igual nos dois grupos. CONCLUSÕES: Embora não haja nenhum efeito considerável sobre a marcação dos componentes do sangue há uma mudança notável na biodistribuição especialmente nos rins. O conhecimento desta mudança na captação de rim pode contribuir para reduzir o risco de erro diagnóstico e/ou a repetição dos exames de Medicina Nuclear.


Subject(s)
Animals , Male , Rats , Blood Cells/metabolism , Brassica/chemistry , Organotechnetium Compounds/pharmacokinetics , Plant Extracts/pharmacokinetics , Radiopharmaceuticals/pharmacokinetics , Sugar Acids/pharmacokinetics , Organ Specificity , Organotechnetium Compounds/blood , Plant Extracts/blood , Rats, Wistar , Radiopharmaceuticals/blood , Sugar Acids/blood , Time Factors , Tissue Distribution
2.
Clinics ; 66(3): 483-486, 2011. tab
Article in English | LILACS | ID: lil-585962

ABSTRACT

Cassia angustifolia Vahl (senna) is a natural product that contains sennosides, which are active components that affect the intestinal tract and induce diarrhea. Authors have shown that senna produces DNA (deoxyribonucleic acid) lesions in Escherichia coli cultures and can act as an antifungal agent. Natural drugs can alter the labeling of blood constituents with technetium-99m (99mTc) and can affect the biodistribution of radiopharmaceuticals. In this work, we have evaluated the influence of a senna extract on the radiolabeling of blood constituents and on the biodistribution of the radiopharmaceutical sodium pertechnetate (Na99mTcO4)in Wistar rats. Twelve animals were treated with senna extract for 7 days. Blood samples were withdrawn from the animals and the radiolabeling procedure was carried out. The senna extract did not modify the radiolabeling of the blood constituents. A biodistributional assay was performed by administering Na99mTcO4 and determining its activity in different organs and in blood. The senna extract altered the biodistribution of Na99mTcO4 in the thyroid, liver, pancreas, lungs and blood. These results are associated with properties of the chemical substances present in the aqueous senna extract. Although these assays were performed in animals, our findings suggest that caution should be exercised when nuclear medicine examinations using Na99mTcO4 are conducted in patients who are using senna extract.


Subject(s)
Animals , Male , Rats , Blood Cells/drug effects , Radiopharmaceuticals/pharmacokinetics , Senna Extract/pharmacology , Senna Plant/chemistry , /pharmacokinetics , Blood Cells/metabolism , Models, Animal , Rats, Wistar , Radiopharmaceuticals/blood , /blood , Time Factors
3.
Article in English | IMSEAR | ID: sea-40494

ABSTRACT

OBJECTIVE: The objective of this study was to determine if a correlation exists between the effective renal plasma flow (ERPF) and the extraction fraction (EF) using 99mTc MAG3 in children. This EF has been previously described with 9mTc DTPA. However, the renal imaging agent of choice has become 9mTc MAG3. MATERIAL AND METHOD: The study was approved by The Children's Hospital of Philadelphia's institutional review board. Informed consent was also obtained A retrospective study of 29 children (16 males, 13 females) of ages 1 month to 19.5 years who underwent 99mTc MAG3 renal scintigraphy from September 2001 to December 2001 was analysed. EF values were calculated with and without attenuation correction in each kidney by determining the counts in a region of interest, correcting for background and comparing the counts with the injected dose. The EF was compared to the ERPF calculated using the Schlegel's method. The correlation between the EF and the ERPF corrected and non-corrected for soft tissue attenuation, were determined and were identified by using linear regression analysis. RESULTS: There was significant correlation between the ERPF and the EF with (r = 0.62, p < 0.05 on the left, r = 0.51, p = 0.005 on the right) than without attenuation correction (r = 0.54, p = 0.003 on the left, r = 0.42, p = 0.022 on the right). CONCLUSION: These results indicate a correlation of the ERPF calculated using the Schlegel's method with EF obtained from a 99mTc MAG3 renal scintigraphy. The EF may be the good alternative parameter for calculation of renal function, potentially more practical in pediatric patient and the ERPF for 99mTc MAG3 using the established software program based on Schlegel's formula.


Subject(s)
Adolescent , Adult , Child , Child, Preschool , Data Interpretation, Statistical , Female , Humans , Infant , Kidney Diseases/physiopathology , Male , Radiopharmaceuticals/blood , Renal Blood Flow, Effective/physiology , Renal Dialysis , Technetium Tc 99m Mertiatide/blood
4.
Rev. med. nucl. Alasbimn j ; 8(32)apr. 2006. tab, graf
Article in English | LILACS | ID: lil-444092

ABSTRACT

A computer program based on a Bayesian statistical model has been developed for calculating tracer clearance from any number of plasma samples drawn at arbitrary time intervals. Bayesian prior parameters were calculated from clinical data for Tc99m-MAG3, Tc99m-EC, I131-OIH, Tc99m-DTPA, and Yb169-DTPA and then used to calculate clearance from prospective data. Clearance estimates using only one or two plasma samples were found to closely approximate the results of using multiple samples. When only one or a few samples are available, the program supplements the observed data by a Bayesian prior probability distribution (based on prior clinical measurements) to achieve agreement with multisample clearance. When many points are available, the observed data overwhelm the prior probability, and results approach those of conventional curve fitting but with less sensitivity to bad data points and less risk of fitting failure.


Subject(s)
Humans , Radiopharmaceuticals/pharmacokinetics , Kidney/physiology , Computer Simulation , Bayes Theorem , Kidney Glomerulus/physiology , Ytterbium/pharmacokinetics , Models, Statistical , Probability , Kidney Function Tests , Radiopharmaceuticals/blood , Iodine Radioisotopes/pharmacokinetics , Metabolic Clearance Rate , Technetium/pharmacokinetics , Kidney Tubules/physiology
5.
Acta cir. bras ; 20(supl.1): 126-130, 2005. tab
Article in English | LILACS | ID: lil-414645

ABSTRACT

OBJETIVO: A marcação de hemácias sangüíneas (C) com 99mTc é muito utilizada nos procedimentos diagnósticos na medicina nuclear. Drogas podem alterar este método de marcação e modificar a biodisponibilidade de radiofármacos. Neste trabalho, foi avaliada a influência de glucantime na marcação de elementos sangüíneos com 99mTc. MÉTODOS: Sangue foi retirado de ratos e incubado com glucantime. Adicionou-se cloreto estanoso e 99mTc. Após centrifugação, plasma (P) e (C) foram isolados. Amostras de P e C foram precipitadas com TCA 5 por cento, centrifugadas e separadas em frações solúveis (FS) e insolúveis (FI). Os percentuais de atividade total injetada (por cento ATI) em C, FI-P e FI-C foram calculados (p<0,05). RESULTADOS: O %ATI em C diminuiu, em relação ao controle, nas seguintes concentrações de glucantime (6,25 por cento;12,5 por cento; 25 por cento; 50 por cento; 100por cento), respectivamente: 94,06±1,29 (controle) para 77,15±2,79; para 76,68±1,88; para 75,15±2,79; para 72,64±4,40 e para 63,05±3,84. Em FI-C, o %ATI diminuiu, em relação ao controle, em todas as concentrações de glucantime (3,125 por cento; 6,25 por cento; 12, 5 por cento; 25 por cento; 50 por cento; 100 por cento), respectivamente: 93,34±1,18 (controle) para 78,81±2,76; para 74,76±4,82; para 74,02±5,32; para 64,35±4,82; para 62,81±1,97 e para 54,55±3,58. CONCLUSÕES: Este efeito provavelmente foi devido a produtos presentes nesta droga que podem se complexar com íons (Sn+2 e 99mTcO-4) ou ter um efeito direto ou indireto na concentração intracelular do íon estanoso.


Subject(s)
Animals , Male , Rats , Erythrocytes , Meglumine/pharmacology , Organometallic Compounds/pharmacology , Radiopharmaceuticals/pharmacokinetics , Technetium/pharmacokinetics , Blood Proteins/metabolism , Erythrocytes/drug effects , Isotope Labeling , Meglumine/blood , Organometallic Compounds/blood , Radiopharmaceuticals/blood , Statistics, Nonparametric , Technetium/blood , Tin Compounds/blood , Tin Compounds , Tissue Distribution/radiation effects
6.
Medicina (B.Aires) ; 60(2): 211-6, 2000. tab
Article in Spanish | LILACS | ID: lil-262213

ABSTRACT

El objetivo del estudio fue medir el F/G con Tc99m DTPA y comparar métodos que emplean tres, dos o una muestra de sangre. Se estudiaron 148 pacientes (54 mujeres y 94 homvres, entre 3-84 años) con diversas enfermedades renales. Después de la administración EV de Tc99m DTPA, se extrajeron 3 (n=44), o dos (n=104) muestras de sangre, calculándose por análisis exponencial la disminución plasmática de actividad por filtración glomerular. El F/G con una muestra de sangre se estimó con los métodos de Jacobsson, Russel, Groth-Aasted, Dakubu y Constable. Resultados: 1) En 37/148 (25 por ciento) el F/G promedio con los métodos 1 y 2 fue inferior a 30 ml/min. La diferencia de las medias entre estos métodos y los que extraen una muestra de sangre fue significativamente alta o baja en el 51 por ciento y 49 por ciento respectivamente. En los restantes 111/148 (75 por ciento) el F/G fue superior a 30 ml/min. Entre los métodos 1 y 2 y determinados métodos que extraen una muestra las diferencias absolutas porcentuales fueron clínicamente aceptables. Sin embargo cada uno de estos métodos, diferen según rangos de filtrado. Por esta razón sugerimos estimar el F/G empleando dos muestras de sangre, y ultrafiltrar el plasma previo al conteo de la muestra para dar mayor exactitud al cálculo del F/G.


Subject(s)
Humans , Male , Female , Child , Child, Preschool , Adolescent , Adult , Middle Aged , Glomerular Filtration Rate , Radiopharmaceuticals , Technetium Tc 99m Pentetate , Aged, 80 and over , Kidney Function Tests/methods , Radiopharmaceuticals/blood , Technetium Tc 99m Pentetate/blood
7.
J. bras. urol ; 24(1): 5-9, jan.-mar. 1998. tab, graf
Article in Portuguese | LILACS | ID: lil-219866

ABSTRACT

Trinta e dois cäes submetidos a entubaçäo do ducto torácico e cateterismo bilateral dos ureteres, foram divididos em 3 grupos: A- 4 cäes inoculados com RISA 131 I ou EDTA 51 Cr por via intravenosa ou peri-prostática; B- controle de 8 cäes submetidos a irrigaçäo vesical e prostática com 8 litros de glicina a 1,2 por cento contendo os marcadores radioativos; C- 8 cäes manejados como em B mas sujeitos à RTU da próstata. Os cäes foram acompanhados por 5 horas. A absorçäo de líquido de irrigaçäo foi calculada pelos métodos volumétrico e radioisotópico. Em 5 horas, 97 por cento da RISA 131 I inoculada via intravenosa permanecia neste espaço enquanto apenas 4,6 por cento da injetada no espaço peri-prostático penetrou no compartimento vascular. Para o EDTA 51 Cr, 63,6 por cento da massa inoculada no espaço peri-prostático foi recuperada na urina após 5 horas. O método volumétrico mostrou absorçäo média de 22,7 ml no grupo B e 276 ml no C, e o radioisotópico de 6,3 ml e 165,4 ml, respectivamente. O modelo experimental tem similaridades com o ser humano


Subject(s)
Animals , Dogs , Absorption/physiology , Edetic Acid/pharmacokinetics , Radiopharmaceuticals/pharmacokinetics , Glycine/pharmacokinetics , Prostatectomy/adverse effects , Chromium Radioisotopes/pharmacokinetics , Serum Albumin, Radio-Iodinated/pharmacokinetics , Radiopharmaceuticals/blood , Radiopharmaceuticals/urine , Glycine/blood , Glycine/urine , Chromium Radioisotopes/blood , Chromium Radioisotopes/urine , Serum Albumin, Radio-Iodinated/blood , Serum Albumin, Radio-Iodinated/urine , Lymphatic System/physiology , Therapeutic Irrigation/adverse effects
8.
Braz. j. med. biol. res ; 31(2): 303-6, feb. 1998. tab
Article in English | LILACS | ID: lil-212577

ABSTRACT

In the present study evaluated the binding of the radiopharmaceuticals sodium pertechnetate (Na (99m)TcO4), methylenediphosphonic acid (99m)Tc-MDP)) and glucoheptonate acid (99m)Tc-GHA)) to blood elements using centrifugation and radioautographic techniques. Heparinized blood was incubated with the labelled compounds for 0, 1, 2, 3, 4, 6 and 24 h. Plasma (P) and blood cells (BC) were isolated and precipitated with 5 percent trichloroacetic acid (TCA), and soluble (SF) and isoluble fractions (IF) were separated. Blood samples were prepared (0 and 24 h) and coated with LM-1 radioautographic emulsions and percent radioactivity (percent rad) in P and BC was determined. The binding of Na (99m)TcO4 (percentrad) to P was 61.2 percent (0 h) and 46.0 percent (24 h), and radioautography showed 63.7 percent (0 h) and 43.3 percent (24 h). The binding to BC was 38.8 percent (0 h) and 54.0 percent (24 h), and radioautography showed 36.3 percent (0h) and 56.7 percent (24 h), and radioautography showed 36.3 percent (0 h) and 56.7 percent (24 h). (99m) Tc-MDP study presented 91.1 percent (0 h) to P and 87.2 percent (24 h), and radioautography showed 67.9 percent (0 h) and 67.4 percent (24 h). The binding to BC was 8.9 percent (0 h) and 12.8 percent (24 h), and radioautography showed 32.1 percent (0 h) and 32.6 percent (24 h). (99m)Tc-GHA study was 90.1 percent (0 h) to P and 79.9 percent (24 h), and radioautography showed 67.2 percent (0 h) and 60.1 percent (24 h). The binding to BC was 9.9 percent (0 h) and 20.1 percent (24 h), and radioautography showed 32.8 percent (0 h) and 39.9 percent (24 h). The comparasion of the obtained results suggests that the binding to plasma and blood cells in the two techniques used (radioautography and centrifugation) qualitatively in accordance.


Subject(s)
Rats , Animals , Blood Cells/chemistry , Phosphorous Acids/blood , Phosphorous Acids/pharmacokinetics , Radiopharmaceuticals/blood , Radiopharmaceuticals/pharmacokinetics , Sodium Pertechnetate Tc 99m/blood , Sodium Pertechnetate Tc 99m/pharmacokinetics , Autoradiography , Centrifugation , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL